Geode Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63B | Buy |
5,928,747
+166,987
| +3% | +$74M | 0.18% | 93 |
|
|
2025
Q1 | $2.78B | Buy |
5,761,760
+113,524
| +2% | +$54.8M | 0.22% | 82 |
|
|
2024
Q4 | $2.27B | Sell |
5,648,236
-287,652
| -5% | -$116M | 0.18% | 90 |
|
|
2024
Q3 | $2.75B | Sell |
5,935,888
-389,420
| -6% | -$181M | 0.22% | 71 |
|
|
2024
Q2 | $2.96B | Buy |
6,325,308
+512,272
| +9% | +$240M | 0.26% | 61 |
|
|
2024
Q1 | $2.42B | Buy |
5,813,036
+139,617
| +2% | +$58.2M | 0.22% | 76 |
|
|
2023
Q4 | $2.3B | Buy |
5,673,419
+77,445
| +1% | +$31.4M | 0.24% | 71 |
|
|
2023
Q3 | $1.94B | Buy |
5,595,974
+51,113
| +0.9% | +$17.7M | 0.23% | 75 |
|
|
2023
Q2 | $1.95B | Buy |
5,544,861
+135,604
| +3% | +$47.6M | 0.23% | 78 |
|
|
2023
Q1 | $1.7B | Buy |
5,409,257
+26,538
| +0.5% | +$8.34M | 0.22% | 87 |
|
|
2022
Q4 | $1.55B | Buy |
5,382,719
+111,052
| +2% | +$32M | 0.22% | 90 |
|
|
2022
Q3 | $1.52B | Buy |
5,271,667
+737,183
| +16% | +$213M | 0.23% | 78 |
|
|
2022
Q2 | $1.28B | Buy |
4,534,484
+204,253
| +5% | +$57.4M | 0.19% | 97 |
|
|
2022
Q1 | $1.13B | Sell |
4,330,231
-25,989
| -0.6% | -$6.76M | 0.14% | 123 |
|
|
2021
Q4 | $954M | Buy |
4,356,220
+53,868
| +1% | +$11.8M | 0.11% | 154 |
|
|
2021
Q3 | $778M | Buy |
4,302,352
+215,173
| +5% | +$38.9M | 0.1% | 172 |
|
|
2021
Q2 | $822M | Buy |
4,087,179
+145,993
| +4% | +$29.4M | 0.11% | 155 |
|
|
2021
Q1 | $845M | Buy |
3,941,186
+54,343
| +1% | +$11.6M | 0.13% | 136 |
|
|
2020
Q4 | $916M | Buy |
3,886,843
+12,691
| +0.3% | +$2.99M | 0.15% | 119 |
|
|
2020
Q3 | $1.05B | Buy |
3,874,152
+33,835
| +0.9% | +$9.19M | 0.21% | 88 |
|
|
2020
Q2 | $1.11B | Buy |
3,840,317
+30,946
| +0.8% | +$8.97M | 0.24% | 76 |
|
|
2020
Q1 | $905M | Buy |
3,809,371
+237,183
| +7% | +$56.3M | 0.24% | 82 |
|
|
2019
Q4 | $780M | Buy |
3,572,188
+115,110
| +3% | +$25.1M | 0.16% | 122 |
|
|
2019
Q3 | $585M | Buy |
3,457,078
+108,297
| +3% | +$18.3M | 0.14% | 149 |
|
|
2019
Q2 | $613M | Buy |
3,348,781
+113,284
| +4% | +$20.7M | 0.15% | 129 |
|
|
2019
Q1 | $594M | Buy |
3,235,497
+176,191
| +6% | +$32.3M | 0.15% | 124 |
|
|
2018
Q4 | $506M | Buy |
3,059,306
+207,934
| +7% | +$34.4M | 0.16% | 121 |
|
|
2018
Q3 | $548M | Buy |
2,851,372
+69,858
| +3% | +$13.4M | 0.15% | 124 |
|
|
2018
Q2 | $472M | Buy |
2,781,514
+48,459
| +2% | +$8.22M | 0.15% | 136 |
|
|
2018
Q1 | $444M | Buy |
2,733,055
+125,804
| +5% | +$20.5M | 0.14% | 139 |
|
|
2017
Q4 | $390M | Buy |
2,607,251
+105,683
| +4% | +$15.8M | 0.13% | 147 |
|
|
2017
Q3 | $380M | Buy |
2,501,568
+114,200
| +5% | +$17.3M | 0.14% | 137 |
|
|
2017
Q2 | $307M | Buy |
2,387,368
+47,547
| +2% | +$6.12M | 0.12% | 172 |
|
|
2017
Q1 | $255M | Buy |
2,339,821
+191,154
| +9% | +$20.9M | 0.1% | 196 |
|
|
2016
Q4 | $158M | Buy |
2,148,667
+102,298
| +5% | +$7.53M | 0.07% | 269 |
|
|
2016
Q3 | $178M | Buy |
2,046,369
+58,820
| +3% | +$5.12M | 0.09% | 230 |
|
|
2016
Q2 | $171M | Buy |
1,987,549
+1,362
| +0.1% | +$117K | 0.09% | 224 |
|
|
2016
Q1 | $158K | Buy |
1,986,187
+40,848
| +2% | +$3.24K | 0.08% | 237 |
|
|
2015
Q4 | $244M | Buy |
1,945,339
+28,873
| +2% | +$3.63M | 0.14% | 141 |
|
|
2015
Q3 | $199M | Buy |
1,916,466
+15,534
| +0.8% | +$1.61M | 0.12% | 170 |
|
|
2015
Q2 | $234M | Sell |
1,900,932
-21,862
| -1% | -$2.69M | 0.13% | 148 |
|
|
2015
Q1 | $226M | Buy |
1,922,794
+89,425
| +5% | +$10.5M | 0.13% | 162 |
|
|
2014
Q4 | $218M | Buy |
1,833,369
+88,144
| +5% | +$10.5M | 0.13% | 159 |
|
|
2014
Q3 | $196M | Buy |
1,745,225
+4,930
| +0.3% | +$553K | 0.13% | 157 |
|
|
2014
Q2 | $165M | Sell |
1,740,295
-1,670
| -0.1% | -$158K | 0.11% | 192 |
|
|
2014
Q1 | $123M | Buy |
1,741,965
+28,146
| +2% | +$1.99M | 0.08% | 243 |
|
|
2013
Q4 | $127M | Buy |
1,713,819
+66,692
| +4% | +$4.95M | 0.09% | 228 |
|
|
2013
Q3 | $125M | Buy |
1,647,127
+740,697
| +82% | +$56.1M | 0.1% | 208 |
|
|
2013
Q2 | $72.4M | Buy |
+906,430
| New | +$72.4M | 0.06% | 310 |
|